Rituximab-Induced Acute ST Elevation Myocardial Infarction

REFERENCES

1. ↵
   1. Bonow RO,
   2. Mann DL,
   3. Zipes DP,
   4. Libby P

   1. Force T,
   2. Chen MH.

   (2011) in Braunwald's Heart Disease. 9th ed, The cancer patient and cardiovascular disease, eds Bonow RO, Mann DL, Zipes DP, Libby P (Elsevier Health Sciences; London, England) In, eds.
2. ↵
   1. Roy A,
   2. Khanna N,
   3. Senguttuvan NB.

   (2, 2014) Rituximab-vincristine chemotherapy-induced acute anterior wall myocardial infarction with cardiogenic shock. Tex Heart Inst J 41(1):80–82, pmid:24512409, doi: 10.14503/THIJ-12-2853.

   OpenUrlCrossRefPubMed
3. ↵
   1. Armitage JD,
   2. Montero C,
   3. Benner A,
   4. Armitage JO,
   5. Bociek G.

   (8, 2008) Acute coronary syndromes complicating the first infusion of rituximab. Clin Lymphoma Myeloma 8(4):253–255, pmid:18765315, doi: 10.3816/CLM.2008.n.035.

   OpenUrlCrossRefPubMed
4. ↵
   1. Seruga B,
   2. Sterling L,
   3. Wang L,
   4. Tannock IF.

   (1 10, 2011) Reporting of serious adverse drug reactions of targeted anticancer agents in pivotal phase III clinical trials. J Clin Oncol 29(2):174–185, pmid:21135271, doi: 10.1200/JCO.2010.31.9624.

   OpenUrlAbstract/FREE Full Text
5. ↵
   1. Mandel EM,
   2. Lewinski U,
   3. Djaldetti M.

   (12, 1975) Vincristine-induced myocardial infarction. Cancer 36(6):1979–1982, pmid:1243105.

   OpenUrlCrossRefPubMedWeb of Science
6. 1. Barra M,
   2. Brignole M,
   3. Sartore B,
   4. Bertulla A.

   (1, 1985) Myocardial infarction induced by vincristine in patients with Hodgkin's lymphoma. Description of 2 cases and review of the literature [in Italian]. G Ital Cardiol 15(1):107–111, pmid:4007346.

   OpenUrlPubMed
7. ↵
   1. Mikaelian I,
   2. Buness A,
   3. de Vera-Mudry MC,
   4. et al.

   (9, 2010) Primary endothelial damage is the mechanism of cardiotoxicity of tubulin-binding drugs. Toxicol Sci 117(1):144–151, pmid:20624997, doi:10.1093/toxsci/kfq189.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. Vlaar PJ,
   2. Mahmoud KD,
   3. Holmes DR Jr.,
   4. et al.

   (8 9, 2011) Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol 58(7):692–703, pmid:21816304, doi:10.1016/j.jacc.2011.03.046.

   OpenUrlFREE Full Text
9. ↵
   1. Bainey KR,
   2. Mehta SR,
   3. Lai T,
   4. Welsh RC.

   (1, 2014) Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis. Am Heart J 167(1):1–14.e2, pmid:24332136, doi: 10.1016/j.ahj.2013.09.018.

   OpenUrlCrossRefPubMed